6533b85bfe1ef96bd12bab12
RESEARCH PRODUCT
The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia
David GrimwadeAntonio R. Lucena-araujoKatia B PagnanoRosane BittencourtEduardo Magalhães RegoFrancesco Lo-cocoAna Paula Alencar De Lima LangeMiguel A. SanzEvandro M. FagundesAna Carolina Stocco De LimaRafael H. JacomoMaria De Lourdes Lopes Ferrari ChauffailleRaul A. M. MeloRicardo PasquiniCarlos S. Chiattonesubject
OncologyAcute promyelocytic leukemiaacute leukaemiamedicine.medical_specialtyacute promyelocytic leukaemiaPROTEÍNAS PROTO-ONCOGÊNICAS03 medical and health sciences0302 clinical medicineInternal medicinemedicineNeoplasmSurvival ratebusiness.industryFollow up studiesHematologymedicine.diseaseMinimal residual diseaseClinical trialLeukemiaPML/RARA; acute leukaemia; acute promyelocytic leukaemia; minimal residual disease; quantitative PCR030220 oncology & carcinogenesisquantitative PCRminimal residual diseaseAcute promyelocytic leukaemiabusinessPML/RARASettore MED/15 - Malattie del Sangue030215 immunologyyear | journal | country | edition | language |
---|---|---|---|---|
2016-12-26 |